Status:
UNKNOWN
Study of the Reduction of the Prescriptions of Benzodiazepines and Related
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Depression in Old Age
Eligibility:
All Genders
75+ years
Brief Summary
The significant consumption of Benzodiazepines and related drugs in the elderly outside of good practice recommendations is a major issue in the care of the elderly. Adverse effects have been the subj...
Detailed Description
The aim of this research is to quantify among the patients who benefited from a dosage reduction of Benzodiazepines and related drugs during a stay in the Geriatric Care and Aftercare and Rehabilitati...
Eligibility Criteria
Inclusion
- Major subject (≥ 75 years old)
- Subject discharged from a geriatric Follow-up Care and Rehabilitation service for whom a reduction in the dosage of Benzodiazepines and related drugs was carried out during hospitalization and who returned home (individual or EHPAD) after hospitalization.
- Subject not opposing, after information, the reuse of their data for the purposes of this research.
Exclusion
- Subject having expressed opposition to participating in the study.
- Subject having treatment with Benzodiazepine to prevent recurrence of epileptic seizures.
Key Trial Info
Start Date :
March 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 17 2024
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06107283
Start Date
March 1 2023
End Date
August 17 2024
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gériatrie - Service de Soins de Soins Médicaux et de Réadaptation - CHU de Strasbourg - France
Strasbourg, France, 67091